JP2006151999A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006151999A5 JP2006151999A5 JP2006055107A JP2006055107A JP2006151999A5 JP 2006151999 A5 JP2006151999 A5 JP 2006151999A5 JP 2006055107 A JP2006055107 A JP 2006055107A JP 2006055107 A JP2006055107 A JP 2006055107A JP 2006151999 A5 JP2006151999 A5 JP 2006151999A5
- Authority
- JP
- Japan
- Prior art keywords
- crystal
- tautomer
- solvate
- formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9713730.1A GB9713730D0 (en) | 1997-06-30 | 1997-06-30 | Organic compounds |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50628799A Division JP3880634B2 (ja) | 1997-06-30 | 1998-06-26 | 結晶性マクロライドおよびその調製方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006151999A JP2006151999A (ja) | 2006-06-15 |
| JP2006151999A5 true JP2006151999A5 (2) | 2006-12-07 |
| JP4504323B2 JP4504323B2 (ja) | 2010-07-14 |
Family
ID=10815103
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50628799A Expired - Lifetime JP3880634B2 (ja) | 1997-06-30 | 1998-06-26 | 結晶性マクロライドおよびその調製方法 |
| JP2006055107A Expired - Lifetime JP4504323B2 (ja) | 1997-06-30 | 2006-03-01 | 結晶性マクロライドおよびその調製方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50628799A Expired - Lifetime JP3880634B2 (ja) | 1997-06-30 | 1998-06-26 | 結晶性マクロライドおよびその調製方法 |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6423722B1 (2) |
| EP (1) | EP0994880B1 (2) |
| JP (2) | JP3880634B2 (2) |
| KR (1) | KR100399765B1 (2) |
| CN (1) | CN1139595C (2) |
| AR (1) | AR017754A1 (2) |
| AT (1) | ATE287410T1 (2) |
| AU (1) | AU739211B2 (2) |
| BR (1) | BR9810956A (2) |
| CA (1) | CA2290412C (2) |
| CO (1) | CO4940463A1 (2) |
| CZ (1) | CZ297244B6 (2) |
| DE (1) | DE69828692T2 (2) |
| DK (1) | DK0994880T3 (2) |
| ES (1) | ES2236922T3 (2) |
| GB (1) | GB9713730D0 (2) |
| HU (1) | HU227755B1 (2) |
| ID (1) | ID24897A (2) |
| IL (1) | IL132761A0 (2) |
| MY (1) | MY118718A (2) |
| NO (1) | NO312765B1 (2) |
| NZ (1) | NZ500994A (2) |
| PE (1) | PE97699A1 (2) |
| PL (1) | PL192761B1 (2) |
| PT (1) | PT994880E (2) |
| RU (1) | RU2219181C2 (2) |
| SK (1) | SK285665B6 (2) |
| TR (1) | TR199903189T2 (2) |
| TW (1) | TW552264B (2) |
| WO (1) | WO1999001458A1 (2) |
| ZA (1) | ZA985655B (2) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9713730D0 (en) * | 1997-06-30 | 1997-09-03 | Ciba Geigy Ag | Organic compounds |
| GB9826656D0 (en) | 1998-12-03 | 1999-01-27 | Novartis Ag | Organic compounds |
| GB0125443D0 (en) * | 2001-10-23 | 2001-12-12 | Novartis Ag | Organic Compounds |
| EP1663220B1 (en) * | 2003-09-03 | 2009-12-02 | Glaxo Group Limited | Novel process for the preparation of pleuromutilin derivatives |
| PT1734927E (pt) * | 2004-04-08 | 2012-09-05 | Meda Pharma S A R L | Composição em espuma de pimecrolimus contendo hexilenoglicol, opcionalmente álcool oleílico, dimetilisossorbida e/ou triglicéridos de cadeia média |
| CA2584430A1 (en) * | 2004-12-01 | 2006-06-08 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Methods for preparing pimecrolimus |
| TW200837067A (en) * | 2006-11-06 | 2008-09-16 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof |
| JP2010512333A (ja) * | 2006-12-07 | 2010-04-22 | ヘルシン ヘルスケア ソシエテ アノニム | 塩酸パロノセトロンの結晶及び非晶質形 |
| US9192697B2 (en) | 2007-07-03 | 2015-11-24 | Hemoteq Ag | Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis |
| EP2944332B1 (en) | 2009-07-10 | 2016-08-17 | Boston Scientific Scimed, Inc. | Use of nanocrystals for a drug delivery balloon |
| EP2453938B1 (en) | 2009-07-17 | 2015-08-19 | Boston Scientific Scimed, Inc. | Nucleation of drug delivery balloons to provide improved crystal size and density |
| EP2611476B1 (en) | 2010-09-02 | 2016-08-10 | Boston Scientific Scimed, Inc. | Coating process for drug delivery balloons using heat-induced rewrap memory |
| US8669360B2 (en) * | 2011-08-05 | 2014-03-11 | Boston Scientific Scimed, Inc. | Methods of converting amorphous drug substance into crystalline form |
| WO2013028208A1 (en) | 2011-08-25 | 2013-02-28 | Boston Scientific Scimed, Inc. | Medical device with crystalline drug coating |
| WO2014145780A1 (en) | 2013-03-15 | 2014-09-18 | Biosensors International Group, Ltd. | Purification of rapamycin derivatives |
| EP3178824A1 (en) | 2015-12-08 | 2017-06-14 | Medichem, S.A. | Process for preparing pimecrolimus |
| ES2906158T3 (es) * | 2017-05-01 | 2022-04-13 | Meda Pharma Gmbh & Co Kg | Proceso para convertir ascomicina bruta en pimecrolimus purificado |
| EP3741367A1 (en) | 2019-05-21 | 2020-11-25 | Premark Pharma GmbH | Treatment of ocular disease |
| WO2024209038A1 (en) | 2023-04-06 | 2024-10-10 | Premark Pharma Gmbh | Use of pimecrolimus for the treatment of dry eye in patients characterized by a corneal staining score of 4 or 5 on the oxford grading scale |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS51118816A (en) * | 1975-04-08 | 1976-10-19 | Meiji Seika Kaisha Ltd | A process for stabilizing non-crystalloidal solid |
| US4127647A (en) * | 1975-04-08 | 1978-11-28 | Meiji Seika Kaisha, Ltd. | Process for preparation of stable amorphous macrolide antibiotic solids |
| CY1306A (en) | 1980-10-01 | 1985-12-06 | Glaxo Group Ltd | Aminoalkyl furan derivative |
| JP2728482B2 (ja) * | 1989-01-26 | 1998-03-18 | 協和醗酵工業株式会社 | マクロライド系抗生物質の精製法 |
| JPH089630B2 (ja) | 1989-07-10 | 1996-01-31 | ヘマ・ソシエダード・アノニマ | 有機化合物の、または関連する改善 |
| DK0427680T3 (da) * | 1989-11-09 | 1995-12-18 | Sandoz Ltd | Heteroatom-holdige cykliske forbindelser |
| EP0594600A1 (en) * | 1990-03-13 | 1994-05-04 | FISONS plc | Immunosuppressive macrocyclic compounds |
| EP0480623A1 (en) * | 1990-10-11 | 1992-04-15 | Merck & Co. Inc. | New halomacrolides and derivatives having immunosuppressive activity |
| US5143918A (en) * | 1990-10-11 | 1992-09-01 | Merck & Co., Inc. | Halomacrolides and derivatives having immunosuppressive activity |
| ES2100291T3 (es) | 1991-07-30 | 1997-06-16 | Ajinomoto Kk | Cristales de n-(trans-4-isopropilciclohexilcarbonil)-d-fenilalanina y metodos para prepararlos. |
| US5247076A (en) | 1991-09-09 | 1993-09-21 | Merck & Co., Inc. | Imidazolidyl macrolides having immunosuppressive activity |
| US5221740A (en) | 1992-01-16 | 1993-06-22 | American Home Products Corporation | Oxepane isomers of rapamycin useful as immunosuppressive agents |
| UA41884C2 (uk) * | 1993-11-05 | 2001-10-15 | Амерікан Хоум Продактс Корпорейшн | Спосіб відокремлення рапаміцину від кислотних, основних та неполярних нейтральних домішок, присутніх в концентраті екстрактів ферментаційного бульйону або маточних розчинів |
| JP3808500B2 (ja) * | 1994-02-22 | 2006-08-09 | キューレータズ オブ ディ ユニバーシティ オブ ミズーリ | 分離剤としての大環状抗生物質 |
| CA2229718A1 (en) * | 1995-08-24 | 1997-03-06 | David J. Mathre | Process for the preparation of imidazolyl macrolide immunosuppressants |
| GB9713730D0 (en) * | 1997-06-30 | 1997-09-03 | Ciba Geigy Ag | Organic compounds |
-
1997
- 1997-06-30 GB GBGB9713730.1A patent/GB9713730D0/en active Pending
-
1998
- 1998-06-25 CO CO98036359A patent/CO4940463A1/es unknown
- 1998-06-26 PL PL336719A patent/PL192761B1/pl unknown
- 1998-06-26 PE PE1998000568A patent/PE97699A1/es not_active IP Right Cessation
- 1998-06-26 JP JP50628799A patent/JP3880634B2/ja not_active Expired - Lifetime
- 1998-06-26 DK DK98936392T patent/DK0994880T3/da active
- 1998-06-26 SK SK1866-99A patent/SK285665B6/sk not_active IP Right Cessation
- 1998-06-26 WO PCT/EP1998/003929 patent/WO1999001458A1/en not_active Ceased
- 1998-06-26 CA CA002290412A patent/CA2290412C/en not_active Expired - Lifetime
- 1998-06-26 PT PT98936392T patent/PT994880E/pt unknown
- 1998-06-26 ES ES98936392T patent/ES2236922T3/es not_active Expired - Lifetime
- 1998-06-26 TR TR1999/03189T patent/TR199903189T2/xx unknown
- 1998-06-26 BR BR9810956-1A patent/BR9810956A/pt not_active Application Discontinuation
- 1998-06-26 NZ NZ500994A patent/NZ500994A/en not_active IP Right Cessation
- 1998-06-26 AT AT98936392T patent/ATE287410T1/de active
- 1998-06-26 AU AU85409/98A patent/AU739211B2/en not_active Expired
- 1998-06-26 RU RU2000101826/04A patent/RU2219181C2/ru active
- 1998-06-26 ID IDW991682A patent/ID24897A/id unknown
- 1998-06-26 DE DE69828692T patent/DE69828692T2/de not_active Expired - Lifetime
- 1998-06-26 IL IL13276198A patent/IL132761A0/xx not_active IP Right Cessation
- 1998-06-26 KR KR10-1999-7010048A patent/KR100399765B1/ko not_active Expired - Lifetime
- 1998-06-26 HU HU0003053A patent/HU227755B1/hu unknown
- 1998-06-26 EP EP98936392A patent/EP0994880B1/en not_active Expired - Lifetime
- 1998-06-26 CN CNB988064677A patent/CN1139595C/zh not_active Expired - Lifetime
- 1998-06-26 CZ CZ0474099A patent/CZ297244B6/cs not_active IP Right Cessation
- 1998-06-26 AR ARP980103094A patent/AR017754A1/es active IP Right Grant
- 1998-06-29 ZA ZA985655A patent/ZA985655B/xx unknown
- 1998-06-29 MY MYPI98002955A patent/MY118718A/en unknown
- 1998-07-21 TW TW087111867A patent/TW552264B/zh not_active IP Right Cessation
-
1999
- 1999-12-02 NO NO19995909A patent/NO312765B1/no not_active IP Right Cessation
-
2000
- 2000-10-17 US US09/690,404 patent/US6423722B1/en not_active Expired - Lifetime
-
2006
- 2006-03-01 JP JP2006055107A patent/JP4504323B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006151999A5 (2) | ||
| CN103261187B (zh) | 制备四唑取代的邻氨基苯甲酰胺衍生物的方法以及这些衍生物的晶体多形体 | |
| JP2020518662A (ja) | 化合物の結晶多形、その製造方法及び用途 | |
| JP2020517611A5 (2) | ||
| CN103951634B (zh) | 一种依帕司他结晶盐水合物和羟基哌啶共晶物及其制备方法和应用 | |
| JP2009537603A (ja) | ５−アミノ−３−（２’，３’−ジ−Ｏ−アセチル−ベータ−Ｄ−リボフラノシル）−３Ｈ−チアゾロ［４，５−ｄ］ピリミジン−２−オンのマレイン酸塩のＡ型及びＢ型結晶形 | |
| JP2014500357A5 (2) | ||
| JP2016537346A5 (2) | ||
| JP2015508092A5 (2) | ||
| RS61986B1 (sr) | Hemisulfat so 5,10-metilen-(6)-tetrahidrofolne kiseline | |
| HRP20251307T1 (hr) | Kristalni oblik trietilentetramin tetrahidroklorida i njegova farmaceutska upotreba | |
| JP2017530146A (ja) | Ｊａｋ阻害剤の硫酸水素塩の結晶形およびその製造方法 | |
| KR102878525B1 (ko) | 피리미디닐아미노-피라졸 화합물의 다형체와 고체 형태, 그리고 생산 방법 | |
| JP2021501127A5 (2) | ||
| JP2016510768A5 (2) | ||
| RU2016106125A (ru) | Соли дасатиниба в кристаллической форме | |
| JP2004513106A (ja) | 塩酸ベンラファキシンの結晶形 | |
| CN103965116B (zh) | 半5-氟胞嘧啶盐、其制备方法及应用 | |
| JP2009040767A5 (2) | ||
| CN102807575B (zh) | 3-芳基-5-噻吩基-5H-噻唑并[3,2-a]嘧啶类衍生物及其应用 | |
| JP2012512145A (ja) | フリバンセリンの結晶性の塩形態 | |
| JP2013541589A5 (2) | ||
| JP2019529553A5 (2) | ||
| CN107033094A (zh) | 一种药物共晶的晶型及其制备方法和组合物 | |
| JP2016527227A (ja) | ペメトレキセドトロメタミン塩の新規な結晶形 |